Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P12955: Variant p.Gly448Arg

Xaa-Pro dipeptidase
Gene: PEPD
Feedback?
Variant information Variant position: help 448 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Arginine (R) at position 448 (G448R, p.Gly448Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PD. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 448 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 493 The length of the canonical sequence.
Location on the sequence: help DPARASFLNREVLQRFRGFG G VRIEEDVVVTDSGIELLTCV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         DPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCV-

Mouse                         DPAQACFFNQEVLQRFRNFGGVRIEEDVVVTDSGMELLTCV

Rat                           DPAQACFFNQEVLQRFRNFGGVRIEEDVVVTDSGMELLTCV

Slime mold                    NPETAKFFNLTELDKYRNIGGVRIEDDILVTETGCDNLSKN
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 493 Xaa-Pro dipeptidase
Binding site 452 – 452
Binding site 452 – 452
Beta strand 448 – 450



Literature citations
Four novel PEPD alleles causing prolidase deficiency.
Ledoux P.; Scriver C.R.; Hechtman P.;
Am. J. Hum. Genet. 54:1014-1021(1994)
Cited for: VARIANTS PD ARG-448 AND GLU-452 DEL; Expression and molecular analysis of mutations in prolidase deficiency.
Ledoux P.; Scriver C.R.; Hechtman P.;
Am. J. Hum. Genet. 59:1035-1039(1996)
Cited for: VARIANTS PD GLN-184; ASP-278; ARG-448 AND GLU-452 DEL; Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts.
Forlino A.; Lupi A.; Vaghi P.; Icaro Cornaglia A.; Calligaro A.; Campari E.; Cetta G.;
Hum. Genet. 111:314-322(2002)
Cited for: VARIANT PD ARG-448;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.